Abbott Laboratories shares owned by Copeland Capital Management
Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by Copeland Capital Management
from 13F filings
Historical chart of Copeland Capital Management investment in Abbott Laboratories
Tip: Access up to 7 years of quarterly data
All positions including Abbott Laboratories held by Copeland Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Abbott Laboratories by Copeland Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $167k | 1.2k | 133.94 |
| 2025-06-30 | $170k | 1.2k | 136.01 |
| 2025-03-31 | $166k | 1.2k | 132.65 |
| 2024-12-31 | $141k | 1.2k | 113.11 |
| 2024-09-30 | $142k | 1.2k | 114.01 |
| 2024-03-31 | $142k | 1.2k | 113.66 |
| 2023-12-31 | $137k | 1.2k | 110.07 |
| 2023-09-30 | $121k | 1.2k | 96.85 |
| 2023-06-30 | $136k | 1.2k | 109.02 |
| 2023-03-31 | $126k | 1.2k | 100.96 |
| 2022-12-31 | $137k | 1.2k | 109.78 |
| 2022-09-30 | $121k | 1.2k | 96.96 |
| 2022-06-30 | $136k | 1.2k | 108.97 |
| 2022-03-31 | $148k | 1.2k | 118.59 |
| 2021-12-31 | $176k | 1.2k | 141.03 |
| 2021-09-30 | $147k | 1.2k | 117.79 |
| 2021-06-30 | $145k | 1.2k | 116.19 |
| 2021-03-31 | $150k | 1.2k | 120.19 |
| 2020-12-31 | $137k | 1.2k | 109.78 |
| 2020-09-30 | $136k | 1.2k | 108.97 |
| 2020-06-30 | $114k | 1.2k | 91.35 |
| 2020-03-31 | $98k | 1.2k | 78.53 |
| 2019-12-31 | $108k | 1.2k | 86.54 |
| 2019-09-30 | $104k | 1.2k | 83.33 |
| 2019-06-30 | $105k | 1.2k | 84.13 |
| 2019-03-31 | $100k | 1.2k | 80.13 |
| 2018-12-31 | $90k | 1.2k | 72.12 |
| 2014-03-31 | $11M | 281k | 38.51 |
| 2013-12-31 | $11M | 278k | 38.33 |
| 2013-09-30 | $9.1M | 274k | 33.19 |
| 2013-06-30 | $8.8M | 253k | 34.88 |
| 2013-03-31 | $10M | 290k | 35.32 |
| 2012-12-31 | $10M | 155k | 65.50 |
| 2012-09-30 | $11M | 158k | 68.56 |
| 2012-06-30 | $10M | 158k | 64.47 |
| 2012-03-31 | $8.5M | 138k | 61.29 |
| 2011-12-31 | $1.3M | 24k | 56.22 |
More positions owned by Copeland Capital Management
View all positions for Copeland Capital Management